
SEB Venture Capital leads SEK 93m round for OssDsign
SEB Venture Capital has led a SEK 93m funding round for Swedish cranio-facial implant maker OssDsign, alongside Swedish VC Fouriertransform and existing investor Karolinska Development.
The fresh capital will be used to fund further expansion into Europe for OssDsign, which currently sells its products in the Nordic countries, Germany and the UK. It plans to launch in Europe and the US in 2016.
Karolinska's follow-on investment in the Uppsala-based company is the first for the VC this year, and comes a month after it sold XSpray Microparticles.
Alongside the appointment of new CEO Jim Van Heusden from Gimv in March, Karolinska has been in the process of streamlining its portfolio this year.
Previous funding
Karolinska first backed OssDsign when the company was founded in 2011, and invested SEK 13.7m in July 2013.
Company
Headquartered in Uppsala near Stockholm, OssDsign is a developer and producer of implants used for permanent cranial repairs.
People
Jim Van Heusden is the CEO of Karolinska Development.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater